Special Virtual Issue: Advances of Liver Diseases

In this special virtual issue, Gastroenterology Report editors have curated a collection of review articles that discus practical approaches to managing common liver diseases, including HCC screening, non-invasive assessment of fibrosis, multifaceted approaches to perioperative care and cirrhotic complications, and postpartum hepatitis flare in mothers with hepatitis B.  All articles in the special issue are Open Access.

Calvin Q Pan, Nancy Reau
Gastroenterology Report, Volume 12, 2024, goae098, https://doi.org/10.1093/gastro/goae098
The landscape of liver disease management continues to evolve, with notable advancements in non-invasive diagnostics, understanding of perioperative risk, new therapies for cirrhotic complications, metabolic dysfunction-associated steatotic liver disease (MASLD), and alcohol-associated liver disease (ALD), as well as screening for hepatocellular carcinoma (HCC) and the management of special populations such as mothers with hepatitis B.
Jimmy Che-To Lai, Lilian Yan Liang, Grace Lai-Hung Wong 
Gastroenterology Report, Volume 12, 2024, goae024, https://doi.org/10.1093/gastro/goae024
Liver fibrosis is the common pathway from various chronic liver diseases and its progression leads to cirrhosis which carries a significant risk for the development of portal hypertension-related complications and hepatocellular carcinoma.
Sameer Bhalla, Brendan Mcquillen, Edward Cay, Nancy Reau
Gastroenterology Report, Volume 12, 2024, goae071, https://doi.org/10.1093/gastro/goae071
The prevalence of liver disease is rising and more patients with liver disease are considered for surgery each year
Jasleen Singh, Mark Ebaid, Sammy Saab
Gastroenterology Report, Volume 12, 2024, goae072, https://doi.org/10.1093/gastro/goae072
Cirrhosis with complications of liver decompensation and hepatocellular carcinoma (HCC) constitute a leading cause of morbidity and mortality worldwide.
Shi OuYang, Yawen Geng, Gongqin Qiu, Yueying Deng, Haitao Deng, Calvin Q Pan
Gastroenterology Report, Volume 12, 2024, goae091, https://doi.org/10.1093/gastro/goae091
Postpartum elevation of alanine aminotransferase (ALT) in mothers with chronic hepatitis B (CHB) presents a significant clinical challenge. However, the existing literature demonstrates inconsistencies regarding its incidence and predictors in mothers infected with the hepatitis B virus (HBV). 
Calvin Q Pan, Andrew J Park, James S Park
Gastroenterology Report, Volume 12, 2024, goae085, https://doi.org/10.1093/gastro/goae085
Achieving a sustained virologic response (SVR) through direct-acting antivirals for hepatitis C virus (HCV) infection significantly reduces the long-term risk of hepatocellular carcinoma (HCC), particularly in patients with advanced fibrosis (F3) or cirrhosis (F4).
Taizo Mori, Sachiyo Yoshio, Eiji Kakazu, Tatsuya Kanto
Gastroenterology Report, Volume 12, 2024, goae089, https://doi.org/10.1093/gastro/goae089
Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD), is a complex multifactorial disease that progresses from steatohepatitis (MASH) to liver cirrhosis and liver cancer. Recent research has revealed that crosstalk between innate immune cells and hepatic parenchymal and non-parenchymal cells is involved in the pathogenesis of liver disease in MASLD/MASH.
Ahmad Anouti, Thomas A Kerr, Mack C Mitchell, Thomas G Cotter
Gastroenterology Report, Volume 12, 2024, goae097, https://doi.org/10.1093/gastro/goae097
Alcohol-associated liver disease (ALD) is a significant global health challenge, encompassing a spectrum from steatotic liver disease to cirrhosis and alcohol-associated hepatitis, and contributed to 25% of global cirrhosis deaths in 2019.
Anthony Kityo, Sang-Ah Lee
Gastroenterology Report, Volume 12, 2024, goad074, https://doi.org/10.1093/gastro/goad074
Binge drinking (BD) has been associated with elevated liver enzymes, but the joint association of BD and adiposity with liver enzymes is understudied.
Zixuan Li, Xiaoying Wu, Zebin Chen, Xiuqing Wei, Weiqing Chen 
Gastroenterology Report, Volume 12, 2024, goad076, https://doi.org/10.1093/gastro/goad076
Recent studies have found that thyroid function may be associated with the occurrence and development of advanced liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease (MAFLD).
Fateh Bazerbachi, Serge Baroud, Michael J Levy, Daniel B Maselli, Eric J Vargas and others
Gastroenterology Report, Volume 12, 2024, goae039, https://doi.org/10.1093/gastro/goae039
Visceral fat represents a metabolically active entity linked to adverse metabolic sequelae of obesity. We aimed to determine if celiac artery mesenteric fat thickness can be reliably measured during endoscopic ultrasound (EUS), and if these measurements correlate with metabolic disease burden.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period